News
A recent phase III randomized trial found an investigational oral small-molecule GLP-1 receptor agonist significantly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback